CervoMed CRVO
NASDAQ CRVO
$3.02 +0.09 (+3.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

CervoMed (CRVO) Asset Writedowns and Impairment (2012 - 2018)

Updated

CervoMed (CRVO) reported Asset Writedowns and Impairment of $2.7 million for Q4 2018, down 35.5% from the prior quarter.

Analysis

CervoMed (CRVO) Asset Writedowns and Impairment (2012 - 2018) Analysis & Trends

For FY2018, CervoMed posted Asset Writedowns and Impairment of $6.93 million.

  • Asset Writedowns and Impairment has a five-year compound annual growth rate of 29.1% (FY2013 to FY2018).
  • By year, Asset Writedowns and Impairment came in at $11.07 million in FY2015 (+66.0%) and $6.67 million in FY2014 (+244.6%).
  • The Q4 2018 figure ranks as the lowest quarterly Asset Writedowns and Impairment since Q4 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 CervoMed 30.94 Mn 30.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 2.70 Mn
Sep 30, 2018 4.19 Mn
Sep 30, 2015 11.07 Mn
Dec 31, 2012 1.23 Mn
API Access

CervoMed Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=CRVO&period=max&api_key=YOUR_API_KEY